Viewing Study NCT00396266

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-01-25 @ 12:10 AM
Study NCT ID: NCT00396266
Status: COMPLETED
Last Update Posted: 2014-03-07
First Post: 2006-11-02
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF
Sponsor: Genzyme, a Sanofi Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Lymphoma, Non-Hodgkin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Hodgkin's Lymphoma View
None Multiple Myeloma View
None stem cell mobilization View
None AMD3100 View
None autologous transplantation View